Search

everythinglearnresearchcommunity

for

Search:↓

Recognize Polish academic titles as proof of language proficiency for foreign-trained doctors.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

BMP signaling controls hair growth and skin color.

Prolactin affects when mice shed and grow hair.

Senescent melanocytes can boost hair growth by activating hair stem cells.

Prolactin affects when mice shed and grow hair.

Calcium signals and SHH guide the direction of feather growth in chicken skin.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Distinct miRNA signatures could help diagnose and treat severe Alopecia Areata.

Non-canonical Wnt signaling helps intestinal stem cells move to injury sites for tissue repair.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Traditional Chinese Medicine and biomaterials help heal chronic wounds by targeting multiple pathways.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

c-Kit is important for heart regeneration and cancer development.

Three compounds from Dadap leaves may help treat hair loss.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.

Recent advances in hair loss treatments show significant progress.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Tofacitinib may effectively regrow hair in alopecia totalis patients.